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Before the study was even open for enrollment, 
the research team reached out to physicians and 
staff in affected departments.  This proved to be 
integral to enrollment success.  The outreach 
went above and beyond a brief in-service or 
presentation.  
The research team met with Emergency 
Department and Cardiac Catheterization Lab 
staff and physicians for an in-depth discussion 
regarding logistics of study implementation.  
Specific questions were addressed at this time.
•  What is the workflow in each department 
and how will the study affect each 
process?
•  How can the study be integrated as 
seamlessly as possible?
•  Can each team identify potential barriers 
and how they can be overcome?
•  What are the main concerns of the clinical 
care areas regarding the study?
•  How can the study team help address all of 
these items?
•  It has been suggested in literature 
that patients in emergent situations, 
such as those suffering from an 
acute myocardial infarction, may 
meet the definition of a vulnerable 
population due to the life-threatening 
nature of the condition
•  Key strategies were employed to 
ensure safe, ethical enrollment of 
this patient population by addressing 
concerns that arose. 
•  Interventions were implemented at 
all stages of study procedures.
 
Ethical Concerns
•  The study team’s ability to perform 
research activities without hindering 
the clinical care of the patient
•  Time-sensitive nature of obtaining 
consent and treatment
•  The patient’s ability to understand 
consent and study requirements
•  Avoiding a sense of coercion for the 
patient due to the fast-paced clinical 





•  CRC’s and physician investigators 
“debriefed” after the first few study 
participants were enrolled to discuss 
informed consent and enrollment for 
each case in order to improve upon 
processes.
•  CRC’s visited patients after their 
procedures (several hours later or 
next day) to once again review the 
consent form and answer any additional 
patient questions in a more relaxed 
environment.
Conclusion
•  Although ethical concerns are inherent 
in all clinical trials, especially with 
emergent patients, conscientious 
enrollment strategies allow for those 
concerns to be addressed.
•  Communication, collaboration, and 
follow-up between the study team, 






Not Every Candidate 
Is a Candidate
•  The clinical research coordinators (CRCs) 
worked with physician investigators to refine 
an informed consent strategy to ensure all 
study elements were adequately explained 
to study subjects in this acute situation.
•  It was decided that the physician 
investigator would initially present the 
study to the patient, with a brief overview 
and focus on the procedural and scientific 
aspects of the study.
•  If the patient indicated interest in 
participating, the CRC would approach the 
patient to provide the informed consent 
document for the patient to review, and offer 
continued explanation of study procedures, 
commitments, and HIPAA language.  The 
CRC would obtain the patient’s signature.
•  The physician was close by in the event the 
patient had additional questions, but this 
allowed the physician to continue in clinical 
decision making and directing of patient 
care during the consent process.
Before a patient was approached, the 
study team confirmed that not only did the 
patient meet inclusion criteria for the trial, 
but that they were able to participate in the 
consenting process.  No legally authorized 
representatives (LARs) were used.
If, in the CRC’s or physician’s opinion, the 
patient was not suitable for consent EVEN if 
study criteria were met, the patient was not 
approached.
•  Reasons why patients were not 
approached:
 -  Heavily medicated in the field
 -  High anxiety/tearfulness
 -  Verbalized reluctance to make decisions 
without significant other/child/parent 
present
 -  Did not appear able to comprehend 
study or consent explanation (possible 
historical dementia, poor understanding 
of English language, etc.)
Takeaway: By implementing the frontloading 
process, the clinical areas were able to voice 
concerns and have an active, collaborative role 
in working through study logistics.  Before the 
study began, all of the affected clinical areas 
were “on the same page,” and anticipating the 
research team’s involvement in upcoming cases.  
This helped to address the ethical concern 
regarding hindrance of the patient’s clinical care.
Takeaway: The “Division of Labor” process 
proved to be the most efficient use of 
the physician and study team’s time, 
and allowed for the most comprehensive 
explanation for the patient, for informed 
consent.
Takeaway: The “unwritten exclusions” 
were mutually agreed upon by the 
study team, and also shared with 
clinical departments
•  CRC’s and study physicians 
supported decisions not to approach 
certain patients.
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